HEALTH

OMAHA, Neb. — Sergeant's Pet Care Products has launched a generic version of a commonly used spray for killing fleas and ticks in dogs and cats, the company said Tuesday.

Sergeant's announced the launch of Pronyl, a version of Sanofi's Frontline. Pronyl uses the same active ingredient, Fipronil, but also uses what the company calls Bag-on-Valve technology that allows a continuous and quiet spray from any angle.

PITTSBURGH — Mylan and Biocon have a deal to develop and sell generic insulin-analog products for diabetes, Mylan said.

Under the deal, Mylan will have the rights to develop and market Biocon's Glargine, Lispro and Aspart, respectively generic versions of Sanofi's Lantus, Eli Lilly's Humalog and Novo Nordisk's NovoLog.

NORTHRIDGE, Calif. — Pharmavite on Tuesday announced that its Voots Veggie-Fruit Tarts brand, a fruit- and vegetable-based supplement for kids ages 4 years and older, are now available for purchase at Walgreens locations nationwide.

NEW YORK — The YMCA is sponsoring a diabetes-control program that some say could slow the disease's spread, according to published reports.

HYDERABAD, India — The Food and Drug Administration has approved a generic diabetes drug made by Aurobindo Pharma, the drug maker said.

Aurobindo announced the approval of pioglitazone tablets in the 15 mg, 30 mg and 45 mg strengths, in addition to the earlier tentative approval it received for pioglitazone and metformin hydrochloride tablets in the 15 mg/500 mg and 15 mg/850 mg strengths.

SILVER SPRING, Md. — The Food and Drug Administration and the Federal Trade Commission last week issued a number of warning letters to distributors of "unapproved medicines," noting that because each of the products identified claimed to prevent or treat the cold or flu, they need to be registered and approved by the FDA. And because none of the ingredients listed are in fact monographed OTC cough, cold or flu symptom relievers, those products would additionally need to be filed as "new drugs."

NEW YORK — Church & Dwight has crafted its first advertising campaign targeting a Spanish-speaking audience for its First Response pregnancy test and ovulation prediction kits, according to a story published in the New York Times Tuesday.